Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Change in Accured Expenses (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Change in Accured Expenses over the past 16 years, most recently at -$3.5 million for Q2 2025.

  • Quarterly results put Change in Accured Expenses at -$3.5 million for Q2 2025, down 159.96% from a year ago — trailing twelve months through May 2025 was -$5.9 million (down 458.08% YoY), and the annual figure for FY2025 was -$5.9 million, down 458.08%.
  • Change in Accured Expenses for Q2 2025 was -$3.5 million at Lifecore Biomedical, Inc. \De\, down from -$886000.0 in the prior quarter.
  • Over the last five years, Change in Accured Expenses for LFCR hit a ceiling of $5.9 million in Q2 2023 and a floor of -$3.5 million in Q2 2025.
  • Median Change in Accured Expenses over the past 5 years was -$702500.0 (2022), compared with a mean of $99166.7.
  • Peak annual rise in Change in Accured Expenses hit 1259.61% in 2021, while the deepest fall reached 2152.52% in 2021.
  • Lifecore Biomedical, Inc. \De\'s Change in Accured Expenses stood at -$2.0 million in 2021, then increased by 9.6% to -$1.8 million in 2022, then crashed by 77.7% to -$3.1 million in 2023, then soared by 59.93% to -$1.3 million in 2024, then tumbled by 177.48% to -$3.5 million in 2025.
  • The last three reported values for Change in Accured Expenses were -$3.5 million (Q2 2025), -$886000.0 (Q1 2025), and -$1.3 million (Q4 2024) per Business Quant data.